Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
2019年1月31日 更新者:Abbott Medical Devices
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT)
The purpose of this study is to investigate whether percutaneous Patent Foramen Ovale (PFO) closure, using the AMPLATZER PFO Occluder, is superior to current standard of care medical treatment in the prevention of recurrent embolic stroke.
研究概览
详细说明
The AMPLATZER PFO Occluder is a percutaneous, transcatheter occlusion device intended for the non-surgical closure of patent foramen ovale in subjects who have had a cryptogenic stroke due to presumed paradoxical embolism within the last 270 days.
研究类型
介入性
注册 (实际的)
980
阶段
- 不适用
扩展访问
不再可用
查看扩展访问记录。
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Alberta
-
Calgary、Alberta、加拿大、T2N 2T9
- University Of Calgary
-
Edmonton、Alberta、加拿大、T6G 2B7
- University of Alberta
-
-
British Columbia
-
New Westminster、British Columbia、加拿大、V3L 3W5
- Royal Columbian Hospital
-
Vancouver、British Columbia、加拿大、V5Z 1M9
- Vancouver General Hospital
-
Vancouver、British Columbia、加拿大、V5Z 1Y6
- St. Paul's Hospital
-
-
Ontario
-
London、Ontario、加拿大、N6G 2V2
- Stroke Prevention & Atherosclerosis Research Center (SPARC) - Robarts Research Institute
-
Toronto、Ontario、加拿大、M5G 2C4
- Toronto General Hospital
-
-
Quebec
-
Montreal、Quebec、加拿大、H1T 1C8
- Montreal Heart Institute
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35249
- University of Alabama
-
-
Arizona
-
Scottsdale、Arizona、美国、85259
- Mayo Clinic
-
-
California
-
Los Angeles、California、美国、90095
- UCLA
-
Los Angeles、California、美国、90033
- LAC + USC Medical Center
-
Oakland、California、美国、94609
- Summit Medical Center
-
San Diego、California、美国、92123
- Sharp Memorial Hospital
-
San Francisco、California、美国、94115
- Kaiser Permanente
-
-
Colorado
-
Denver、Colorado、美国、80262
- University of Colorado
-
Littleton、Colorado、美国、80120
- South Denver Cardiology Associates
-
Loveland、Colorado、美国、80538
- Medical Center of the Rockies
-
-
District of Columbia
-
Washington、District of Columbia、美国、20010
- Washington Hospital Center
-
Washington、District of Columbia、美国、20037
- George Washington University Hospital
-
-
Florida
-
Jacksonville、Florida、美国、32204
- St. Vincent's Medical Center
-
-
Illinois
-
Chicago、Illinois、美国、60637-1470
- University of Chicago
-
Chicago、Illinois、美国、60611-3078
- Northwestern University
-
Palos Heights、Illinois、美国、60463
- Neurologic Associates Inc
-
Peoria、Illinois、美国、61637
- OSF St. Francis Medical Center
-
Springfield、Illinois、美国、62702
- Southern Illinois University Neurology
-
-
Indiana
-
Indianapolis、Indiana、美国、46237
- Indiana Heart Physicians
-
-
Iowa
-
Des Moines、Iowa、美国、50314
- Ruan Neurology
-
Iowa City、Iowa、美国、52242
- University of Iowa Hospitals and Clinics
-
-
Kansas
-
Kansas City、Kansas、美国、66160
- Kansas University Medical Center
-
-
Kentucky
-
Lexington、Kentucky、美国、40536
- University of Kentucky
-
-
Louisiana
-
New Orleans、Louisiana、美国、70121
- Ochsner Clinic Foundation
-
-
Maryland
-
Towson、Maryland、美国、21014
- Midatlantic Cardiovascular Associates
-
-
Massachusetts
-
Boston、Massachusetts、美国、02111
- Tufts Medical Center
-
-
Michigan
-
Ann Arbor、Michigan、美国、48109-0316
- University of Michigan Health System
-
-
Minnesota
-
Duluth、Minnesota、美国、55805
- St. Mary's Duluth Clinic
-
Minneapolis、Minnesota、美国、55455
- University of Minnesota
-
Minneapolis、Minnesota、美国、55407
- Abbott Northwestern Hospital
-
Saint Louis Park、Minnesota、美国、55426
- Methodist Hospital/Park Nicollet Medical Center
-
-
Missouri
-
Saint Louis、Missouri、美国、63110
- Washington University
-
-
Nebraska
-
Omaha、Nebraska、美国、68198-2045
- University of Nebraska Medical Center
-
-
New Jersey
-
Cherry Hill、New Jersey、美国、08034
- Our Lady of Lourdes Medical Center
-
Newark、New Jersey、美国、07103
- University of Medicine and Dentistry of New Jersy
-
-
New York
-
Albany、New York、美国、12208
- Albany Medical Center
-
Amherst、New York、美国、14226
- Dent Neurologic Institute
-
Rochester、New York、美国、14642
- University of Rochester
-
-
North Carolina
-
Durham、North Carolina、美国、27710
- Duke University Medical Center
-
Greensboro、North Carolina、美国、27410
- Moses H. Cone Memorial Hospital
-
-
Ohio
-
Akron、Ohio、美国、44320
- Neurology and Neuroscience Associates
-
Cleveland、Ohio、美国、44106
- University Hospitals of Cleveland
-
Columbus、Ohio、美国、43210
- Ohio State University
-
-
Oregon
-
Portland、Oregon、美国、97225
- Providence St. Vincent's Medical Center
-
Portland、Oregon、美国、97329
- Oregon Stroke Center, OHSU
-
-
Pennsylvania
-
Allentown、Pennsylvania、美国、18105
- LeHigh Valley Hospital
-
Hershey、Pennsylvania、美国、17033
- Penn State Milton South Hershey Medical Center
-
Lancaster、Pennsylvania、美国、17543
- Lancaster General Hospital
-
Langhorne、Pennsylvania、美国、19067
- St. Mary's Medical Center
-
-
South Carolina
-
Charleston、South Carolina、美国、29425
- Medical University of South Carolina
-
-
South Dakota
-
Sioux Falls、South Dakota、美国、57108
- North Central Heart Institute
-
-
Tennessee
-
Nashville、Tennessee、美国、37232-8802
- Vanderbilt University
-
Nashville、Tennessee、美国、37205
- St. Thomas Neurology
-
-
Texas
-
Dallas、Texas、美国、75390-8897
- UT Southwestern Medical School
-
Houston、Texas、美国、77030
- University of Texas Houston Health Science Center
-
-
Virginia
-
Virginia Beach、Virginia、美国、23454
- Sentara Virginia Beach General Hospital
-
-
Washington
-
Seattle、Washington、美国、98104
- UW Medicine Stroke Center
-
-
West Virginia
-
Charleston、West Virginia、美国、25304
- Charleston Area Medical Center
-
-
Wisconsin
-
Madison、Wisconsin、美国、53792
- University of Wisconsin Hospital
-
Marshfield、Wisconsin、美国、54449
- Marshfield Clinic
-
Milwaukee、Wisconsin、美国、53226
- Medical College of Wisconsin
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 60年 (成人)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Subjects who have had a cryptogenic stroke within the last 270 days
- Subjects who have been diagnosed with a Patent Foramen Ovale (PFO)
- Subjects willing to participate in follow-up visits
Exclusion Criteria:
- Subjects with intracardiac thrombus or tumor
- Subjects who have an acute or recent (within 6 months) myocardial infarction or unstable angina
- Subjects with left ventricular aneurysm or akinesis
- Subjects with atrial fibrillation/atrial flutter (chronic or intermittent)
- Subjects with another source of right to left shunt identified at baseline, including an atrial septal defect and/or fenestrated septum
- Subjects with contraindication to aspirin or Clopidogrel therapy
- Pregnant or desire to become pregnant within the next year
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Device
AMPLATZER PFO Occluder
|
patent foramen ovale closure device
|
|
有源比较器:Standard or Care - Medical Management
Medical treatment with Aspirin alone, Coumadin alone, Clopidogrel alone, or Aspirin combined with dipyridamole.
|
Medical management - aspirin alone, Coumadin alone, Clopidogrel alone, aspirin combined with dipyridamole
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Composite of Recurrent Nonfatal Ischemic Stroke, Fatal Ischemic Stroke, or Early Death After Randomization
大体时间:Trial enrollment was stopped once 25 unique subjects were mutually adjudicated by the CEC and DSMB as having experienced a primary endpoint event. This occurred on December 20, 2011. The mean follow-up time was 2.6 years.
|
Nonfatal stroke is defined as: focal neurological deficit presumed to be due to focal ischemia, and either 1) symptoms persisting 24 hours or greater, or 2) symptoms persisting less than 24 hours but associated with MR or CT imaging findings of a new, neuroanatomically relevent, cergral infarct. Post-randomization death is defined as: in the MM group as all-cause mortality within 45 days after randomization, and in the device group as all-cause mortality 30 days after implant or 45 days after randomizaiton, whichever occurs last. |
Trial enrollment was stopped once 25 unique subjects were mutually adjudicated by the CEC and DSMB as having experienced a primary endpoint event. This occurred on December 20, 2011. The mean follow-up time was 2.6 years.
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Rate of Complete PFO Closure (Assessed by TEE Bubble Study) at the 6-month Follow-up in the Device Group
大体时间:6 months
|
6 months
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Jeffrey Saver, MD、UCLA Stroke Center
- 首席研究员:John D Carroll, MD、University of Colorado, Denver
- 首席研究员:Richard Smalling, MD、University of Texas Houston Health Science Center
- 首席研究员:David Thaler, MD、Tufts Medical Center
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.
- Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440.
有用的网址
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2003年8月1日
初级完成 (实际的)
2012年5月1日
研究完成 (实际的)
2016年5月1日
研究注册日期
首次提交
2007年4月23日
首先提交符合 QC 标准的
2007年4月23日
首次发布 (估计)
2007年4月24日
研究记录更新
最后更新发布 (实际的)
2019年2月18日
上次提交的符合 QC 标准的更新
2019年1月31日
最后验证
2019年1月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.